Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue

AIDS

Volumn 13, Issue 1, 1999, Pages

  Ruiz, Lidia ^a   Van Lunzen, Jan ^b   Arno, Albert ^a   Stellbrink, Hans Jürgen ^b   Schneider, Claus ^b   Rull, Miquel ^c   Castellà, Elena ^c   Ojanguren, Isabel ^c   Richman, Douglas D ^d   Clotet, Bonaventura ^a   Tenner Racz, Klara ^e   Racz, Paul ^e  

^a Retrovirology Laboratory   (Spain)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Antiviral therapy; Asymptomatic HIV infection; Combination therapy; Latency; Lymph node; Nucleoside analogue; Plasma viraemia; Protease inhibitor

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; DENDRITIC CELL; FLOW CYTOMETRY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; IN SITU HYBRIDIZATION; LEUKOCYTE COUNT; LYMPH NODE BIOPSY; LYMPHOID TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRION; VIRUS CULTURE; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; COCULTURE TECHNIQUES; DENDRITIC CELLS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LYMPHOID TISSUE; NUCLEOSIDES; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 0033035705     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00001     Document Type: Article

References (21)

1. 1. Carpenter CC, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society-USA panel. JAMA 1998, 280:78-86.
2. 2. Knowles DM, Chadburn A: Lymphadenopathy and the lymphoid neoplasms associated with AIDS. In Neoplastic Hematology. Edited by Knowles DM. Baltimore: Williams & Wilkins; 1992:773-835.
3. 3. Rácz P, Tenner-Ràcz K, Kahl C, Feller AC, Kern P, Dietrich M: Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes. Prog Allergy 1986, 37:81-181.
4. 4. Lafeuillade A, Chollet L, Hittinger G, Profizi N, Costes O, Poggi C: Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/ml. J Infect Dis 1998, 177:235-238.
5. 5. Wong JK, Günthard HF, Havlir DV, et al.: Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A 1997, 94:12574-12579.
6. 6. Cavert W, Notermans DW, Staskus K, et al.: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
7. 7. Tenner-Racz, K, Stellbrink HJ, van Lunzen J, et al.: The unenlarged lymph nodes of HIV-1 infected asymptomatic patients with high CD4 cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998, 187:949-959.
8. 8. Stellbrink HJ, van Lunzen J, Hufert FT, et al.: Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymphnode CD4+ T cells. AIDS 1997, 11:1103-1110.
9. 9. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
10. 10. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
11. 11. Wong JK, Hezareh M, Günthard HF, et al.: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
12. 12. Lafeuillade A, Poggi C, Tamalet C, Profizi N: Human immunodeficiency type-1 dynamics in different lymphoid tissue compartments. J Infect Dis 1997, 176:804-806.
13. 13. Günthard HF, Wong JK, Ignacio CC, et al.: Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol 1998, 72:2422-2428.
14. 14. Mulder J, Resnick R, Saget B, et al.: A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J Clin Microbiol 1997, 35:278-280.
15. 15. Schockmel CA, Yerly S, Perrin L: Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:179-183.
16. 16. Fox CH, Tenner-Racz K, Racz P, Fripo A, Pizzo PA, Fauci AS: Lymphoid germinal centers are reservoirs for human immunodeficiency virus type 1 RNA. J Infect Dis 1991, 164:1051-1057.
17. 17. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L: Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol 1992, 30:1787-1790.
18. 18. Jackson JB, Kwok SY, Sninsky JJ, et al.: Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol 1990, 28:16-19.
19. 19. Arnó A, Ruiz L, Juan M, et al.: Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years. AIDS 1998, 12:697-704.
20. 20. Haase AT, Henry K, Zupancic M, et al.: Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996, 274:985-989.
21. 21. Gulick RM, Mellors JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997, 337:734-739.